Doses - TERBUTALINE SULFATE

Dogs:

a) 0.01 mg/kg SQ q4h; 0.03 mg/kg PO q8h (Davis 1985)
b) 2.5 mg PO q8h (Papich 1986)
c) 2.5 - 5 mg PO q8h; 0.625 mg/10 lbs body weight PO q8h (McConnell and Hughey1987)

Cats:

a) 0.01 mg/kg SQ q4h; 0.03 mg/kg PO q8h (Davis 1985)
b) 1.25 mg PO q12h (Papich 1986)

Horses:

a) 0.0033 mg/kg IV (Robinson 1987)
b) 0.025 mg/kg once daily PO; 0.0033 mg/kg IV (Schultz 1986)
c) 0.13 mg/kg PO q8h (McConnell and Hughey 1987)
d) 30 mg PO tid (in a 450 kg horse); usually used in combination with aminphylline andprednisone. (Duran 1992)
Monitoring Parameters -

1) Clinical symptom improvement; auscultation

2) Cardiac rate, rhythm (if indicated)

3) Serum potassium, early in therapy if animal susceptible to hypokalemia
Client Information - Contact veterinarian if animal's condition deteriorates or becomes acutely ill.
Dosage Forms/Preparations/FDA Approval Status/Withholding Times - Veterinary-Approved Products: None

Human-Approved Products:

Terbutaline Sulfate Oral Tablets 2.5 mg, 5 mg; Brethine® (Geigy); Bricanyl® (Hoechst Marion Roussel); (Rx)
Terbutaline Injection 1 mg/ml in 2 ml amps with 1 ml fill; Brethine® (Geigy), Bricanyl®S(Hoechst Marion Roussel); (Rx)
Also available in a metered-dose inhaler.